UCHL3 and renal cell adenocarcinoma: According to the GO analysis, UCHL3 expressed in CD8+ T cells could inhibit the activation of RCC-infiltrating T cells, whereas UCHL5 may impede vacuolar transport instead of antigen processing and presentation in B cells infiltrating RCC.